BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19383288)

  • 21. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
    Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
    Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.
    Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
    Mol Cell Biol; 2006 Apr; 26(7):2570-82. PubMed ID: 16537903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
    Hinrichsen R; Hansen AH; Haunsø S; Busk PK
    Cell Prolif; 2008 Oct; 41(5):813-29. PubMed ID: 18700867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
    Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
    Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
    Satriyo PB; Su CM; Ong JR; Huang WC; Fong IH; Lin CC; Aryandono T; Haryana SM; Deng L; Huang CC; Tzeng YM; Chao TY; Liu HW; Yeh CT
    Toxicol Appl Pharmacol; 2021 Jul; 422():115493. PubMed ID: 33727089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
    Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
    J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
    Tong W; Pollard JW
    Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.
    Le XF; Bedrosian I; Mao W; Murray M; Lu Z; Keyomarsi K; Lee MH; Zhao J; Bast RC
    Cell Cycle; 2006 Aug; 5(15):1654-61. PubMed ID: 16861913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
    Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP
    Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal.
    Cornwell JA; Crncec A; Afifi MM; Tang K; Amin R; Cappell SD
    Nature; 2023 Jul; 619(7969):363-370. PubMed ID: 37407814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Cdk2 is a functional homolog of budding yeast Ime2, the meiosis-specific Cdk-like kinase.
    Szwarcwort-Cohen M; Kasulin-Boneh Z; Sagee S; Kassir Y
    Cell Cycle; 2009 Feb; 8(4):647-54. PubMed ID: 19197163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postnatal Schwann cell proliferation but not myelination is strictly and uniquely dependent on cyclin-dependent kinase 4 (cdk4).
    Atanasoski S; Boentert M; De Ventura L; Pohl H; Baranek C; Beier K; Young P; Barbacid M; Suter U
    Mol Cell Neurosci; 2008 Mar; 37(3):519-27. PubMed ID: 18191580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDK2 regulation through PI3K and CDK4 is necessary for cell cycle progression of primary rat hepatocytes.
    Wierød L; Rosseland CM; Lindeman B; Oksvold MP; Grøsvik H; Skarpen E; Huitfeldt HS
    Cell Prolif; 2007 Aug; 40(4):475-87. PubMed ID: 17635516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I; Polyak K; Iavarone A; Massagué J
    Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cdk1 is sufficient to drive the mammalian cell cycle.
    Santamaría D; Barrière C; Cerqueira A; Hunt S; Tardy C; Newton K; Cáceres JF; Dubus P; Malumbres M; Barbacid M
    Nature; 2007 Aug; 448(7155):811-5. PubMed ID: 17700700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation.
    Bockstaele L; Bisteau X; Paternot S; Roger PP
    Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.